NBEA Gene Variant Linked to Developmental Delays and Seizures
Researchers studied a specific genetic change in the NBEA gene in a child from China who had developmental delays and epilepsy.
Genetics
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
What you’ll find in this topic:
- Plain-language summaries of new epilepsy studies
- What the research means for real life
- Practical questions to ask your neurologist
- Related topics you can explore next
Genetics: What Families Usually Want to Know
- What “genetic epilepsy” means (and what it doesn’t)
- When genetic testing is worth asking about
- What test results can change (treatment, prognosis, family planning)
- How to interpret “variant of uncertain significance” (VUS)
Common Genetics Terms in Plain English
- Gene variant: A change in DNA (sometimes important, often harmless)
- Pathogenic / likely pathogenic: Strong evidence it can cause disease
- VUS: Not enough evidence yet (common, may be reclassified later)
- De novo: Not inherited, happened “new” in the child
- Mosaicism: Variant exists in some cells but not others
Related Topics
Genetics FAQ
Is genetic testing only for kids?
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
If we find a gene, does it change treatment?
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
What if the result is VUS?
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Do negative results mean it’s not genetic?
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
-
-
New Insights on DHDDS Variants and Epilepsy in Japanese Patients
This study looked at a group of Japanese patients with specific genetic changes known as DHDDS variants, which are linked to severe epilepsy and movement disorders.
-
Perampanel Shows Promise for Treating Severe Tremors
Researchers studied the use of a medication called perampanel, which is already approved for treating seizures in epilepsy, to see if it could help people with severe tremors.
-
New Insights on Tuberous Sclerosis in Greece
This study looked at Tuberous Sclerosis Complex (TSC), a rare genetic disorder, in Greece.
-
Pediatricians Need Better Training on Epilepsy Care
A study was conducted in Jordan to understand how well pediatricians and pediatric residents know about epilepsy and its management.
-
Cenobamate Reduces Focal Seizures in Asian Adults
A study was conducted to evaluate how effective a medication called cenobamate is for adults with uncontrolled focal epilepsy.
-
Positive Seizure Control in Children with DEND Syndrome
Researchers studied three children diagnosed with DEND syndrome, which includes developmental delay, epilepsy, and neonatal diabetes.
-
Epilepsy Affects 14% of Nigerians, Especially Children
This study focused on understanding epilepsy in Nigeria, looking at how common it is, the types of seizures people experience, and how they are treated.
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics
Fenfluramine Shows Promise for Drug-Resistant Epilepsy Treatment
Researchers studied the effectiveness and safety of fenfluramine as a treatment for people with drug-resistant epilepsy, particularly those with conditions like Dravet syndrome and Lennox-Gastaut syndrome.
